AMA00970

AMA00970

Sticking to the principle of "Super Quality, Satisfactory service" ,We are striving to be a good business partner of you for ama00970, C700, HSF antobody, PAG2 antobody, Histone H3/c antobody. We sincerely welcome friends from all over the world to cooperate with us on the basis of long-term mutual benefits. We pay high attention to customer service, and cherish every customer. We've maintained a strong reputation in the industry for many years. We are honest and work on building a long-term relationship with our customers. P0CG49, Interferon regulatory factor 7, NRCLP1 ELISA kit, ICF1 antobody.

Related Products

Human CA9 / Carbonic Anhydrase 9 ELISA Kit

Human CA9 / Carbonic Anhydrase 9 ELISA Kit

Read More
anti-CD23 antibody [2G8] (Biotin)

anti-CD23 antibody [2G8] (Biotin)

anti-Hsp 40 antibody

anti-Hsp 40 antibody

Recombinant Human Interleukin-22

Recombinant Human Interleukin-22

anti-Mitochondrial antibody [AE-1]

anti-Mitochondrial antibody [AE-1]

anti-Acinus antibody

anti-Acinus antibody

anti-CCM2 antibody

anti-CCM2 antibody

Top Selling Products

  • Related Blog
  • Reviews

  • 【arigo】双十一，就该买 1 送 1

    双十一光棍节， arigoPLEX® 多因子试剂盒要脱单。 即日起至 11 月 15 日止， arigoPLEX®多因子试剂盒买一送一。 买到不剁手，错过难回首。 立马挑选 arigoPLEX®多因子试剂盒! * 可选不同货号，价高者计。 * 终端客户独享，不限购买数目。 * 不与其他优惠并用。

  • 谷氨酰胺、CAF、TAM，当它们同在肿瘤微环境

    谷氨酰胺代谢对于癌症进展扮演重要角色，其影响不只在于肿瘤细胞本身、也通过改变肿瘤微环境来促进癌细胞生长、侵袭、转移。

  • 突破前列腺癌治疗瓶颈，揪出前列腺癌耐药元凶——“破局者” AR-V7

    这款兔单抗凭什么成为黄金靶点，撑起前列腺癌科研与诊断的“黄金标准”？ 在全球男性恶性肿瘤发病率排名中，前列腺癌常年位居前列。2024年全球癌症报告最新发布：前列腺癌的发病率位于男性恶性肿瘤的第二位，仅次于肺癌。随着精准医疗的深入发展，一个名为雄激素受体剪接变异体7（AR-V7）的生物标志物逐渐成为破解去势抵抗性前列腺癌（CRPC）治疗困境的核心靶点。

  • Porcine Reproductive and RespiratorySyndrome Virus Antibody Test Kit(PRRS X3 Ab)

    Porcine Reproductive and RespiratorySyndrome Virus Antibody Test Kit(PRRS X3 Ab), the kit is an enzyme.linked immunosorbent assay(ELISA)designed to detect PRRS antibodies inserum samples.

  • Nrf2 抑制铜死亡，证据来了

    Nrf2 是抗氧化反应的关键转录因子。铜死亡是 2022 年新发现的由于线粒体铜积累和蛋白毒性应激所引发的程序性细胞死亡。近期数篇论文证实 Nrf2 会抑制铜死亡。

  • AREX Biosciences Ltd. Secures Official Sales Distribution Authorization from RevMAb Biosciences USA, Inc.

    Hangzhou, China – July 19, 2024 – AREX Biosciences Ltd. is pleased to announce that it has been officially authorized as a sales distributor for RevMAb Biosciences USA, Inc. antibody products within the territory of China. This authorization f

  • Janice 2017.08.18 18:38

    The company leader recept us warmly, through a meticulous and thorough discussion, we signed a purchase order. Hope to cooperate smoothly

  • Amy 2018.02.08 16:45

    The factory workers have rich industry knowledge and operational experience, we learned a lot in working with them,we are extremely grateful that we can encount a good company has excellent wokers.

  • Sally 2018.07.12 12:19

    After the signing of the contract, we received satisfactory goods in a short term, this is a commendable manufacturer.

  • Gladys 2018.12.11 11:26

    This is a reputable company, they have a high level of business management, good quality product and service, every cooperation is assured and delighted!

  • Michelle 2017.03.08 14:45

    Speaking of this cooperation with the Chinese manufacturer, I just want to say"well dodne", we are very satisfied.

  • Marjorie 2018.09.21 11:01

    The company can keep up with the changes in this industry market, product updates fast and the price is cheap, this is our second cooperation, it's good.

related search

Room 315, West Zone, Building A, No. 525 Xixi Road, Xihu District, Hangzhou, China 310013
info@arexbio.com
400-886-0853
0571-8708-1890
0571-8708-2185
Products Antibodies - Primary antibodies - Secondary antibodies - Antibody Pairs and Panels - Isotype Controls - Antigen & Cell Lysate - Reagents Kits - ELISA Kit - arigoQIK ELISA - Multiplex ELISA Kits - Assay Kit Recombinant Proteins
Research Areas 基础科学研究 动物科学 生物制药 临床与诊断
Application WB ELISA IHC IP/ChIP IF/ICC FACS
About 关于AREX 新闻发布 市场活动 活动与优惠 联系我们
Linkedin wechat
© AREX 2024. All Rights Reserved. | 浙ICP备2024113709号-3 Sitemap